AU2002348942A1 - Process for the preparation of tofisopam and new intermediates - Google Patents

Process for the preparation of tofisopam and new intermediates

Info

Publication number
AU2002348942A1
AU2002348942A1 AU2002348942A AU2002348942A AU2002348942A1 AU 2002348942 A1 AU2002348942 A1 AU 2002348942A1 AU 2002348942 A AU2002348942 A AU 2002348942A AU 2002348942 A AU2002348942 A AU 2002348942A AU 2002348942 A1 AU2002348942 A1 AU 2002348942A1
Authority
AU
Australia
Prior art keywords
tofisopam
preparation
new intermediates
intermediates
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002348942A
Other languages
English (en)
Other versions
AU2002348942A8 (en
Inventor
Zoltan Greff
Erika Molnarne Samu
Gyula Simig
Pal Vago
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0105326A external-priority patent/HU225411B1/hu
Priority claimed from HU0105327A external-priority patent/HUP0105327A3/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of AU2002348942A1 publication Critical patent/AU2002348942A1/en
Publication of AU2002348942A8 publication Critical patent/AU2002348942A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002348942A 2001-12-13 2002-12-12 Process for the preparation of tofisopam and new intermediates Abandoned AU2002348942A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
HUP0105327 2001-12-13
HUP0105326 2001-12-13
HU0105326A HU225411B1 (en) 2001-12-13 2001-12-13 Process for producing tofisopam
HU0105327A HUP0105327A3 (en) 2001-12-13 2001-12-13 Process for the production of 3-[2-(3,4-dimethoxybenzoyl)-4,5-dimethoxyphenyl]-pentane-2-one
PCT/HU2002/000141 WO2003050092A2 (en) 2001-12-13 2002-12-12 Process for the preparation of tofisopam and new intermediates

Publications (2)

Publication Number Publication Date
AU2002348942A1 true AU2002348942A1 (en) 2003-06-23
AU2002348942A8 AU2002348942A8 (en) 2003-06-23

Family

ID=89979996

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002348942A Abandoned AU2002348942A1 (en) 2001-12-13 2002-12-12 Process for the preparation of tofisopam and new intermediates

Country Status (7)

Country Link
EP (1) EP1465879A2 (cs)
AU (1) AU2002348942A1 (cs)
BG (1) BG108801A (cs)
CZ (1) CZ2004792A3 (cs)
PL (1) PL370036A1 (cs)
SK (1) SK2792004A3 (cs)
WO (1) WO2003050092A2 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227044B1 (en) * 2002-12-16 2010-05-28 Egis Gyogyszergyar Nyilvanosan Process for producing 3-[2-(3,4-dimethoxybenzoyl)-4,5-dimethoxyphenyl]-pentan-2-one
FR2996845A1 (fr) * 2012-10-12 2014-04-18 Servier Lab Nouveau procede de synthese du 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA712798B (en) * 1970-11-06 1972-02-23 Egyt Gyogyszervegyeszeti Gyar New,pharmaceutically active 2,3-diazabicyclo(5.4.0)undecapentaene derivative and process for preparing same

Also Published As

Publication number Publication date
WO2003050092A2 (en) 2003-06-19
WO2003050092A3 (en) 2003-11-06
EP1465879A2 (en) 2004-10-13
PL370036A1 (en) 2005-05-16
AU2002348942A8 (en) 2003-06-23
BG108801A (en) 2005-04-30
CZ2004792A3 (cs) 2004-12-15
SK2792004A3 (en) 2004-11-03

Similar Documents

Publication Publication Date Title
AU2002364528A1 (en) Bio-implant and method of making the same
AU2002314466A1 (en) Withasol and methods of use
AU2001294549A1 (en) Process and intermediates
AU2002312431A1 (en) Novel process for preparing rac-bicalutamide and its intermediates
AU2001293891A1 (en) New combination for the treatment of asthma
AU2002325845A1 (en) Preparation process for atorvastatin and intermediates
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
EP1578723A3 (en) Process for the preparation of oxazolidinones and method of use thereof
AU2002367959A1 (en) Process for the preparation of oxazolidinones and method of use thereof
AU2002337843A1 (en) Processes for the preparation of substituted isoxazoles and 2-isoxazolines
AU1651001A (en) Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
AU2002329441A1 (en) Process for the preparation of 3 - isochromanone
AU2002348942A1 (en) Process for the preparation of tofisopam and new intermediates
AU2002358085A1 (en) Process for the preparation of 4-methyl-7-aminoquinolones
AU5415900A (en) Process for the preparation of butoxycarbonylimino compounds and intermediates therefor
AU2002360409A1 (en) Methods and intermediates for the synthesis of azepines
AU2002324291A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
AU2002342414A1 (en) Novel processes for the preparation of adenosine compounds and intermediates thereto
AU2002232017A1 (en) Process of preparing paroxetine and intermediates for use therein
AU2002359898A1 (en) Preparation of alpha-diimines
AU2000234564A1 (en) Intermediates for vitamin d and processes for the preparation thereof
AU2001228796A1 (en) Process for manufacturing simvastatin and the novel intermediates
AU2002344436A1 (en) Processes for preparation of cyclopropylethanol, cyclo- propylacetonitrile and intermediates of both
HK1060885A (en) New process for the preparation of oxabispidines
AU2001288227A1 (en) Antivesicant compounds and methods of making and using thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase